Your browser doesn't support javascript.
loading
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
Mahmood, Tahir; Minnier, Jessica; Ito, Matthew K; Li, Qian H; Koren, Andrew; Kam, Ivy W; Fazio, Sergio; Shapiro, Michael D.
Affiliation
  • Mahmood T; Oregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology, USA.
  • Minnier J; Oregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology, USA.
  • Ito MK; Oregon Health & Science University, OHSU-PSU School of Public Health, USA.
  • Li QH; Sanofi, USA.
  • Koren A; Regeneron Pharmaceuticals Inc., USA.
  • Kam IW; Sanofi, USA.
  • Fazio S; Regeneron Pharmaceuticals Inc., USA.
  • Shapiro MD; Oregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology, USA.
Eur J Prev Cardiol ; 28(8): 816-822, 2021 07 23.
Article in En | MEDLINE | ID: mdl-34298554
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lipoprotein(a) / Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors / Cholesterol, LDL / Anticholesteremic Agents Type of study: Clinical_trials / Risk_factors_studies / Systematic_reviews Limits: Humans / Male / Middle aged Language: En Journal: Eur J Prev Cardiol Year: 2021 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lipoprotein(a) / Antibodies, Monoclonal, Humanized / PCSK9 Inhibitors / Cholesterol, LDL / Anticholesteremic Agents Type of study: Clinical_trials / Risk_factors_studies / Systematic_reviews Limits: Humans / Male / Middle aged Language: En Journal: Eur J Prev Cardiol Year: 2021 Document type: Article Affiliation country: Estados Unidos